Skip to main content
Erschienen in: World Journal of Surgery 2/2010

01.02.2010

Factors Influencing the Long-Term Survival in Patients with Esophageal Cancer Who Underwent Esophagectomy After Chemoradiotherapy

verfasst von: Hiroya Takeuchi, Yoshiro Saikawa, Takashi Oyama, Soji Ozawa, Koichi Suda, Norihito Wada, Tsunehiro Takahashi, Rieko Nakamura, Naoyuki Shigematsu, Nobutoshi Ando, Masaki Kitajima, Yuko Kitagawa

Erschienen in: World Journal of Surgery | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Salvage esophagectomy is potentially the only treatment available that can offer a chance of long-term survival when definitive chemoradiotherapy (CRT) fails to achieve local control for patients with esophageal squamous cell carcinoma (ESCC). However, salvage esophagectomy is a highly invasive procedure with various postoperative complications compared to planned esophagectomy after neoadjuvant chemoradiotherapy (CRT). We hypothesize that severe postoperative complications may affect not only surgical mortality but also tumor recurrence and long-term survival for patients with salvage esophagectomy after definitive CRT.

Methods

For the present study we reviewed the surgical procedures, postoperative complications, and the prognosis of 65 consecutive patients with thoracic ESCC who underwent the esophagectomy after neoadjuvant (neoadjuvant group: n = 40) or definitive (salvage group: n = 25) CRT.

Results

Most patients underwent right-transthoracic extended esophagectomy and reconstruction using gastric conduit by way of subcutaneous route with left cervical anastomosis. The incidence of postoperative pneumonia was found to be higher in the salvage group than in the neoadjuvant group. In both groups, the survival of patients with R0 resection was significantly better than those with R1/R2 resection. Moreover, in the salvage group, the postoperative survival rate of patients with pneumonia or bacteremia/sepsis was significantly lower than that for patients who did not suffer the same complications. In the neoadjuvant group, R0 resection was selected to be the only independent prognostic factor in univariate and multivariate analysis. In contrast, in the salvage group, R0 resection and bacteremia/sepsis remained significant and were independent of the other factors in multivariate analysis.

Conclusions

This study reveals that postoperative morbidity affects not only the perioperative mortality but also the long-term survival of patients with ESCC who undergo salvage esophagectomy after definitive CRT.
Literatur
1.
Zurück zum Zitat Ando N, Ozawa S, Kitagawa Y et al (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232CrossRefPubMed Ando N, Ozawa S, Kitagawa Y et al (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232CrossRefPubMed
2.
Zurück zum Zitat Takeuchi H, Ozawa S, Ando N et al (2003) Cell cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol 10:792–800CrossRefPubMed Takeuchi H, Ozawa S, Ando N et al (2003) Cell cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol 10:792–800CrossRefPubMed
3.
Zurück zum Zitat Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group. JAMA 281:1623–1627CrossRefPubMed Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group. JAMA 281:1623–1627CrossRefPubMed
4.
Zurück zum Zitat Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ (2007) Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 94:1059–1066CrossRefPubMed Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ (2007) Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 94:1059–1066CrossRefPubMed
5.
Zurück zum Zitat Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3) N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425–433CrossRefPubMed Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3) N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425–433CrossRefPubMed
6.
Zurück zum Zitat Tachimori Y, Kanamori N, Uemura N et al (2009) Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137:49–54CrossRefPubMed Tachimori Y, Kanamori N, Uemura N et al (2009) Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137:49–54CrossRefPubMed
7.
Zurück zum Zitat Hirai T, Yamashita Y, Mukaida H et al (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576–579CrossRefPubMed Hirai T, Yamashita Y, Mukaida H et al (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576–579CrossRefPubMed
8.
Zurück zum Zitat Japanese Esophageal Society (2007) Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, 10th edn. Kanehara Publishing Co, Tokyo Japanese Esophageal Society (2007) Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, 10th edn. Kanehara Publishing Co, Tokyo
9.
Zurück zum Zitat Takeuchi H, Ikeuchi S, Kawaguchi Y et al (2007) Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg 31:2160–2167CrossRefPubMed Takeuchi H, Ikeuchi S, Kawaguchi Y et al (2007) Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg 31:2160–2167CrossRefPubMed
10.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB et al (1992) ACCP/SCCM consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655CrossRefPubMed Bone RC, Balk RA, Cerra FB et al (1992) ACCP/SCCM consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655CrossRefPubMed
11.
Zurück zum Zitat Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234CrossRefPubMed Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234CrossRefPubMed
12.
Zurück zum Zitat Nakamura T, Hayashi K, Ota M et al (2004) Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 188:261–266CrossRefPubMed Nakamura T, Hayashi K, Ota M et al (2004) Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 188:261–266CrossRefPubMed
13.
Zurück zum Zitat Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317CrossRefPubMed Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317CrossRefPubMed
14.
Zurück zum Zitat Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD1902. J Clin Oncol 25:1160–1168CrossRefPubMed Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD1902. J Clin Oncol 25:1160–1168CrossRefPubMed
15.
Zurück zum Zitat Minski BD, Pajak TF, Ginsberg RJ et al (2002) INT0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRef Minski BD, Pajak TF, Ginsberg RJ et al (2002) INT0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRef
16.
Zurück zum Zitat D’Journo X, Michelet P, Dahan L et al (2008) Indications and outcome of salvage surgery for oesophageal cancer. Eur J Cardiothorac Surg 33:1117–1123CrossRefPubMed D’Journo X, Michelet P, Dahan L et al (2008) Indications and outcome of salvage surgery for oesophageal cancer. Eur J Cardiothorac Surg 33:1117–1123CrossRefPubMed
17.
Zurück zum Zitat Lee Y, Fujita H, Yamana H, Kakegawa T (1994) Factors affecting leakage following esophageal anastomosis. Surg Today 24:24–29CrossRefPubMed Lee Y, Fujita H, Yamana H, Kakegawa T (1994) Factors affecting leakage following esophageal anastomosis. Surg Today 24:24–29CrossRefPubMed
18.
Zurück zum Zitat Aiko S, Yoshizumi Y, Sugiura Y et al (2001) Beneficial effects of immediate enteral nutrition after esophageal cancer surgery. Surg Today 31:971–978CrossRefPubMed Aiko S, Yoshizumi Y, Sugiura Y et al (2001) Beneficial effects of immediate enteral nutrition after esophageal cancer surgery. Surg Today 31:971–978CrossRefPubMed
19.
Zurück zum Zitat Kawabata K, Hagio T, Matsumoto S et al (2000) Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med 161:2013–2018PubMed Kawabata K, Hagio T, Matsumoto S et al (2000) Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med 161:2013–2018PubMed
20.
Zurück zum Zitat Suda K, Kitagawa Y, Ozawa S et al (2007) Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus 20:478–486CrossRefPubMed Suda K, Kitagawa Y, Ozawa S et al (2007) Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus 20:478–486CrossRefPubMed
21.
Zurück zum Zitat Shimada H, Ochiai T, Okazumi S et al (2000) Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 128:791–798CrossRefPubMed Shimada H, Ochiai T, Okazumi S et al (2000) Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 128:791–798CrossRefPubMed
22.
Zurück zum Zitat Sato N, Koeda K, Ikeda K et al (2002) Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 236:184–190CrossRefPubMed Sato N, Koeda K, Ikeda K et al (2002) Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 236:184–190CrossRefPubMed
23.
Zurück zum Zitat Tsukada K, Miyazaki T, Katoh H et al (2006) Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer. Dig Liver Dis 38:240–244CrossRefPubMed Tsukada K, Miyazaki T, Katoh H et al (2006) Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer. Dig Liver Dis 38:240–244CrossRefPubMed
24.
Zurück zum Zitat Raimondi AM, Guimarães HP, Amaral JL et al (2006) Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma. Sao Paulo Med J 124:112–115CrossRefPubMed Raimondi AM, Guimarães HP, Amaral JL et al (2006) Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma. Sao Paulo Med J 124:112–115CrossRefPubMed
25.
Zurück zum Zitat Tsujimoto H, Ichikura T, Ono S et al (2009) Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Ann Surg Oncol 16:311–318CrossRefPubMed Tsujimoto H, Ichikura T, Ono S et al (2009) Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Ann Surg Oncol 16:311–318CrossRefPubMed
26.
Zurück zum Zitat Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22CrossRefPubMed Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22CrossRefPubMed
27.
Zurück zum Zitat Adib-Conquy M, Cavaillon J. (2009) Compensatory anti-inflammatory response syndrome. Thromb Haemost 101:36–47 Adib-Conquy M, Cavaillon J. (2009) Compensatory anti-inflammatory response syndrome. Thromb Haemost 101:36–47
28.
Zurück zum Zitat Mynster T, Christensen IJ, Moesgaard F et al (2000) Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer Danish RANX05 Colorectal Cancer Study Group. Br J Surg 87:1553–1562CrossRefPubMed Mynster T, Christensen IJ, Moesgaard F et al (2000) Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer Danish RANX05 Colorectal Cancer Study Group. Br J Surg 87:1553–1562CrossRefPubMed
Metadaten
Titel
Factors Influencing the Long-Term Survival in Patients with Esophageal Cancer Who Underwent Esophagectomy After Chemoradiotherapy
verfasst von
Hiroya Takeuchi
Yoshiro Saikawa
Takashi Oyama
Soji Ozawa
Koichi Suda
Norihito Wada
Tsunehiro Takahashi
Rieko Nakamura
Naoyuki Shigematsu
Nobutoshi Ando
Masaki Kitajima
Yuko Kitagawa
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 2/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0331-9

Weitere Artikel der Ausgabe 2/2010

World Journal of Surgery 2/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.